AbCellera Partners with Vertex to Develop Multispecific T-Cell Engagers
VANCOUVER, British Columbia, July 29, 2026 AbCellera Biologics Inc. announced a strategic collaboration with Vertex Pharmaceuticals to research, develop,...
Drug Discovery
Advertisement
Calidi Biotherapeutics Highlights CLD-401 Cancer Therapy Data
SAN DIEGO, July 27, 2026 Calidi Biotherapeutics presented new preclinical data from its CLD-401 program and its in situ...
Biohaven and Yale Secure Major Win in MODA Technology Dispute
NEW HAVEN, Conn., July 27, 2026 Biohaven Ltd. and Yale University have secured a significant legal victory after a...
Nona Biosciences and MedUni Vienna Collaborate on Infectious Diseases
CAMBRIDGE, Massachusetts, July 23, 2026 Nona Biosciences has announced a strategic research collaboration with the Medical University of Vienna...
Aqemia Broadens AI Drug Discovery Research with Sanofi
PARIS & LONDON, July 17, 2026 Aqemia, the biotechnology company pioneering physics-based generative artificial intelligence (AI) for drug discovery,...
Advertisements
Sinopia Reports Positive Preclinical Parkinson’s Findings
SAN DIEGO, July 15, 2026 Sinopia Biosciences announced the publication of preclinical research in Science Translational Medicine supporting SB-0110,...
Chai Discovery Secures $400M to Transform AI Drug Discovery
SAN FRANCISCO, July 17, 2026 Chai Discovery has announced the successful completion of a $400 million Series C financing...
Insilico Medicine Partners Bora for AI Drug Innovation
HONG KONG & TAIPEI, Taiwan, July 14, 2026 Insilico Medicine and Bora Pharmaceuticals Co., Ltd. have announced a landmark...
VERAXA Partners with Ardigen on AI Cancer Discovery
ZURICH, Switzerland, July 13, 2026 VERAXA Biotech announced a strategic collaboration with AI-driven computational biology company Ardigen to accelerate...
Bristol Myers Squibb NDA for Mezigdomide Accepted by FDA
PRINCETON, New Jersey, July 13, 2026 Bristol Myers Squibb (BMS) has announced that the U.S. Food and Drug Administration...
Advertisement
